InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,959.88
(
2.31%
)
Post# of 52074
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

held2long

Send PM Follow Ignore
Followers 5
Posts 515
Boards Moderated 0
Alias Born 05/24/2010

held2long

Re: 17yr_man post# 27534

Wednesday, 02/06/2013 3:04:54 PM

Wednesday, February 06, 2013 3:04:54 PM

Post# of 52074
17yr - It was precisely because of prompting that he responded. Questions to IR and the realization that there was ambiguity in understanding the advantages that Asepticsure has over the competing technologies. Why they don’t respond similarly to other ambiguities e.g. patent delay etc..is still a puzzlement to me.

>> Shannon responded to the efficacy discussion, apparently without prompting
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up